Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07171164

A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, San Francisco

San Francisco, California, 94110, United States

Location status: Recruiting

Location contact

RSV Uptake Study Coordinator

CONTACT

[email protected]

415-608-8339

About this study

In this type 1 hybrid-implementation study, the investigators will utilize a well-established community-academic partnership to achieve multiple aims. In the Motivate phase, the study will randomize 400 Latino older adults to community health worker (CHW) counseling and text message nudges vs. CHW delivered RSV vaccine vs. text-message nudges alone. The primary outcome in the Motivate phase is RSV vaccine uptake. In the Activate phase, using a parallel design, investigators will randomize 350 Latino adults (18-49 years) to CHW 'activation' counseling to encourage them to discuss RSV vaccine with people over 50 and older in their network plus text-message nudges, vs. text-message nudges alone. The primary outcome for the Activate phase is the average proportion of older adults in participants' social network with whom they discussed RSV vaccination. Interventions in both phases will be adapted using community-based participatory research principles.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Motivate Aim Inclusion Criteria:

  • Age 50 years or older
  • Self-identify as Latino/a/x and/or indigenous groups from Latin America
  • Eligible for RSV vaccination per current CDC/ACIP recommendations
  • Fluent in Spanish or English
  • Has not received the RSV vaccine
  • Has a cell phone
  • Lives or works in San Francisco or Daly City
  • Able to provide informed consent

Motivate Aim Exclusion Criteria:

  • Intent to move outside of San Francisco or Daly City in the next year
  • Nursing home resident
  • Household member participating in Aim 1 or 2
  • Unable to provide consent

Motivate Aim Inclusion Criteria:

  • Age 18-49 years
  • Self-identify as Latino/a/x and/or indigenous groups from Latin America
  • Fluent in English or Spanish
  • Has >1 family member or friend 50 years or older who they have seen or spoken to for >15 minutes in the last 6 months and who lives in the United States

Activate Trial Exclusion Criteria:

  • Household member enrolled in Aim 1 or 2
  • Unable to provide consent

Treatment and study plan

Motivate Aim: CHW text message reminders and counseling

Behavioral

Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage RSV vaccine uptake.

Motivate Aim: CHW text message reminders only

Behavioral

Participants receive text message reminders along with information about RSV and the RSV vaccine to encourage vaccine uptake, but do not receive the counseling intervention

Activate Aim: CHW text message reminders and counseling

Behavioral

Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage discussion of RSV vaccine uptake among older adults in their social networks

Activate Aim: CHW text message reminders only

Behavioral

Participants receive text message reminders along with information about RSV and the vaccine to encourage discussion of RSV vaccine uptake among older adults in their social networks, but do not receive the counseling intervention

Primary outcomes

  1. Motivate Aim Primary Outcome - RSV Vaccine Uptake

    Time frame: 60 days from study enrollment

    RSV vaccine uptake at 60 days per California Immunization Registry (CAIR) or per medical record

  2. Activate Aim Primary Outcome - Proportion of Contacts with whom RSV Vaccination Discussed

    Time frame: 60 days after study enrollment

    Self-reported average proportion of social network contacts 50 years or older with whom participant discussed RSV vaccination at 60 days

Study contacts

Contact information is provided by the study sponsor or research team.

RSV Uptake Study Coordinator

CONTACT

[email protected]

415-608-8339

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Mission Language Vocational School
  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Official study title

Motivate Vaccinate Activate: An Effectiveness-Implementation Trial to Assess the Impact of a Multi-Component Community-Based Intervention to Increase RSV Vaccine Uptake Among Latino Older Adults

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Sep 12, 2025
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.